Please enable JavaScript to continue using this application.

Compare $COGT vs $ORKA | Chartloom

Compare

$COGT vs $ORKA

Cogent Biosciences Inc · Oruka Therapeutics Inc

COGT

Cogent Biosciences Inc

ORKA

Oruka Therapeutics Inc

Compare $COGT vs $ORKA

Comparing Cogent Biosciences Inc and Oruka Therapeutics Inc

COGTCogent Biosciences Inc

ORKAOruka Therapeutics Inc

COGTCogent Biosciences Inc

Market cap

$5.30B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

24.59x

Rev growth (TTM)

—

YTD performance

-10.8%

52W performance

99.0%

FCF yield

-5.8%

ORKAOruka Therapeutics Inc

Market cap

$4.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

190.4%

52W performance

263.0%

FCF yield

-2.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

COGT

ORKA

Detailed metrics comparison

COGT

Cogent Biosciences Inc

ORKA

Oruka Therapeutics Inc

Market Cap

COGT$5.30B

ORKA$4.95B

Enterprise Value

COGT$5.34B

ORKA$4.68B

Price

COGT$31.00

ORKA$82.11

P/E Ratio

COGTN/A

ORKAN/A

P/S Ratio

COGT232.42x

ORKA119.42x

EV/Sales

COGT234.24x

ORKA113.69x

EV/EBITDA

COGT0.00x

ORKA0.00x

P/B Ratio

COGT10.11x

ORKA5.02x

P/FCF Ratio

COGTN/A

ORKAN/A

EV/FCF

COGT-17.27x

ORKA-46.30x

PEG Ratio

COGTN/A

ORKAN/A

Forward P/E (NTM)

COGTN/A

ORKAN/A

Forward P/S (NTM)

COGT24.59x

ORKAN/A

Revenue (TTM)

COGT$0

ORKA$0

Revenue Growth (YoY)

COGTN/A

ORKAN/A

Forward Rev Growth

COGT2636.5%

ORKA679.2%

Gross Margin (TTM)

COGT0.0%

ORKA0.0%

Operating Margin (TTM)

COGT0.0%

ORKA0.0%

EBITDA Margin (TTM)

COGT0.0%

ORKA0.0%

Net Margin (TTM)

COGT0.0%

ORKA0.0%

FCF Margin (TTM)

COGTN/A

ORKAN/A

Net Income (TTM)

COGT$-332M

ORKA$-133M

FCF (TTM)

COGT$-309M

ORKA$-101M

EPS (TTM)

COGT-$1.94

ORKA-$2.11

ROE (TTM)

COGT-7257.0%

ORKA-2076.0%

ROA (TTM)

COGT-4865.0%

ORKA-2012.0%

ROIC (TTM)

COGT-5402.0%

ORKA-2076.0%

Cash

COGT$181M

ORKA$268M

Debt

COGT$223M

ORKA$0

Net Cash/Debt

COGT$-42M

ORKA$268M

Current Ratio (TTM)

COGT13.57x

ORKA38.51x

Quick Ratio (TTM)

COGT13.36x

ORKA38.03x

Debt/Equity (TTM)

COGT0.42x

ORKA0.00x

Debt/Assets (TTM)

COGT0.0%

ORKA0.0%

Interest Coverage (TTM)

COGTN/A

ORKAN/A

Net Debt/EBITDA (TTM)

COGT0.00x

ORKA0.00x

Beta

COGT0.34

ORKA-0.40

52W Performance

COGT99.0%

ORKA263.0%

YTD Performance

COGT-10.8%

ORKA190.4%

% from 52W High

COGT-29.1%

ORKA-28.9%

% from 52W Low

COGT125.0%

ORKA279.1%

Asset Turnover (TTM)

COGT0.36x

ORKA0.33x

FCF Yield (TTM)

COGT-5.8%

ORKA-2.0%

Earnings Yield (TTM)

COGT-6.3%

ORKA-2.7%

Dividend Yield (TTM)

COGTN/A

ORKAN/A

Rule of 40

COGT0.0

ORKA0.0

EV/GP/RG

COGTN/A

ORKAN/A

Ticker research

View COGT research View ORKA research

Metric	COGT Cogent Biosciences Inc	ORKA Oruka Therapeutics Inc
Market & Valuation
Market Cap	$5.30B	$4.95B
Enterprise Value	$5.34B	$4.68B
Price	$31.00	$82.11
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	119.42x
EV/Sales	234.24x	113.69x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.11x	5.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-46.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	2636.5%	679.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-332M	$-133M
FCF (TTM)	$-309M	$-101M
EPS (TTM)	-$1.94	-$2.11
ROE (TTM)	-7257.0%	-2076.0%
ROA (TTM)	-4865.0%	-2012.0%
ROIC (TTM)	-5402.0%	-2076.0%
Financial Health
Cash	$181M	$268M
Debt	$223M	$0
Net Cash/Debt	$-42M	$268M
Current Ratio (TTM)	13.57x	38.51x
Quick Ratio (TTM)	13.36x	38.03x
Debt/Equity (TTM)	0.42x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	-0.40
52W Performance	99.0%	263.0%
YTD Performance	-10.8%	190.4%
% from 52W High	-29.1%	-28.9%
% from 52W Low	125.0%	279.1%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.33x
FCF Yield (TTM)	-5.8%	-2.0%
Earnings Yield (TTM)	-6.3%	-2.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COGT research	View ORKA research

Valuation

P/S Ratio

ORKA

119.42x

COGT

232.42x

EV/FCF

ORKA

-46.30x

COGT

-17.27x

Growth & revenue

Forward Revenue Growth

COGT

2636.5%

ORKA

679.2%

Profitability & performance

Gross Margin

COGT

0.0%

ORKA

0.0%

ROE

ORKA

-2076.0%

COGT

-7257.0%

FCF Yield %

ORKA

-2.0%

COGT

-5.8%

52-Week Performance

ORKA

263.0%

COGT

99.0%

Detailed metrics comparison

COGT

Cogent Biosciences Inc

ORKA

Oruka Therapeutics Inc

Market Cap

COGT$5.30B

ORKA$4.95B

Enterprise Value

COGT$5.34B

ORKA$4.68B

Price

COGT$31.00

ORKA$82.11

P/E Ratio

COGTN/A

ORKAN/A

P/S Ratio

COGT232.42x

ORKA119.42x

EV/Sales

COGT234.24x

ORKA113.69x

EV/EBITDA

COGT0.00x

ORKA0.00x

P/B Ratio

COGT10.11x

ORKA5.02x

P/FCF Ratio

COGTN/A

ORKAN/A

EV/FCF

COGT-17.27x

ORKA-46.30x

PEG Ratio

COGTN/A

ORKAN/A

Forward P/E (NTM)

COGTN/A

ORKAN/A

Forward P/S (NTM)

COGT24.59x

ORKAN/A

Revenue (TTM)

COGT$0

ORKA$0

Revenue Growth (YoY)

COGTN/A

ORKAN/A

Forward Rev Growth

COGT2636.5%

ORKA679.2%

Gross Margin (TTM)

COGT0.0%

ORKA0.0%

Operating Margin (TTM)

COGT0.0%

ORKA0.0%

EBITDA Margin (TTM)

COGT0.0%

ORKA0.0%

Net Margin (TTM)

COGT0.0%

ORKA0.0%

FCF Margin (TTM)

COGTN/A

ORKAN/A

Net Income (TTM)

COGT$-332M

ORKA$-133M

FCF (TTM)

COGT$-309M

ORKA$-101M

EPS (TTM)

COGT-$1.94

ORKA-$2.11

ROE (TTM)

COGT-7257.0%

ORKA-2076.0%

ROA (TTM)

COGT-4865.0%

ORKA-2012.0%

ROIC (TTM)

COGT-5402.0%

ORKA-2076.0%

Cash

COGT$181M

ORKA$268M

Debt

COGT$223M

ORKA$0

Net Cash/Debt

COGT$-42M

ORKA$268M

Current Ratio (TTM)

COGT13.57x

ORKA38.51x

Quick Ratio (TTM)

COGT13.36x

ORKA38.03x

Debt/Equity (TTM)

COGT0.42x

ORKA0.00x

Debt/Assets (TTM)

COGT0.0%

ORKA0.0%

Interest Coverage (TTM)

COGTN/A

ORKAN/A

Net Debt/EBITDA (TTM)

COGT0.00x

ORKA0.00x

Beta

COGT0.34

ORKA-0.40

52W Performance

COGT99.0%

ORKA263.0%

YTD Performance

COGT-10.8%

ORKA190.4%

% from 52W High

COGT-29.1%

ORKA-28.9%

% from 52W Low

COGT125.0%

ORKA279.1%

Asset Turnover (TTM)

COGT0.36x

ORKA0.33x

FCF Yield (TTM)

COGT-5.8%

ORKA-2.0%

Earnings Yield (TTM)

COGT-6.3%

ORKA-2.7%

Dividend Yield (TTM)

COGTN/A

ORKAN/A

Rule of 40

COGT0.0

ORKA0.0

EV/GP/RG

COGTN/A

ORKAN/A

Ticker research

View COGT research View ORKA research

Metric	COGT Cogent Biosciences Inc	ORKA Oruka Therapeutics Inc
Market & Valuation
Market Cap	$5.30B	$4.95B
Enterprise Value	$5.34B	$4.68B
Price	$31.00	$82.11
P/E Ratio	N/A	N/A
P/S Ratio	232.42x	119.42x
EV/Sales	234.24x	113.69x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.11x	5.02x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.27x	-46.30x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	24.59x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	2636.5%	679.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-332M	$-133M
FCF (TTM)	$-309M	$-101M
EPS (TTM)	-$1.94	-$2.11
ROE (TTM)	-7257.0%	-2076.0%
ROA (TTM)	-4865.0%	-2012.0%
ROIC (TTM)	-5402.0%	-2076.0%
Financial Health
Cash	$181M	$268M
Debt	$223M	$0
Net Cash/Debt	$-42M	$268M
Current Ratio (TTM)	13.57x	38.51x
Quick Ratio (TTM)	13.36x	38.03x
Debt/Equity (TTM)	0.42x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.34	-0.40
52W Performance	99.0%	263.0%
YTD Performance	-10.8%	190.4%
% from 52W High	-29.1%	-28.9%
% from 52W Low	125.0%	279.1%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.33x
FCF Yield (TTM)	-5.8%	-2.0%
Earnings Yield (TTM)	-6.3%	-2.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View COGT research	View ORKA research